+987.9%
MRNA vs MSFU
-2.2%
+990.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MSFU | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +13.5% | -0.4% | +10.4% |
| 7D | +20.6% | +8.2% | +12.5% | +18.7% |
| 30D | +27.1% | +10.2% | +17.0% | +24.9% |
| 3M | +353.4% | +22.9% | +330.5% | +337.2% |
| 6M | +446.3% | +63.2% | +383.1% | +396.2% |
| YTD | +776.2% | +11.7% | +764.4% | +682.2% |
| 1Y | +987.9% | -3.5% | +991.4% | +909.1% |
| All | +987.9% | -2.2% | +990.1% | +909.1% |
Cumulative growth
Daily Returns
Daily percentage return beside MSFU.
Daily Out/Under-Performance
Portfolio return minus MSFU return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MSFU return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MSFU wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling